DE1005759B - Zur Bestimmung von Blutgruppen verwendbare Karte - Google Patents
Zur Bestimmung von Blutgruppen verwendbare KarteInfo
- Publication number
- DE1005759B DE1005759B DEN5823A DEN0005823A DE1005759B DE 1005759 B DE1005759 B DE 1005759B DE N5823 A DEN5823 A DE N5823A DE N0005823 A DEN0005823 A DE N0005823A DE 1005759 B DE1005759 B DE 1005759B
- Authority
- DE
- Germany
- Prior art keywords
- conglutinin
- serum
- card
- sera
- substitute
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims description 36
- 239000008280 blood Substances 0.000 title claims description 36
- 210000002966 serum Anatomy 0.000 claims description 68
- 108010018927 conglutinin Proteins 0.000 claims description 49
- QCUFYOBGGZSFHY-UHFFFAOYSA-N depsidomycin Chemical compound O=C1C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(NC=O)C(C)CC)C(C)OC(=O)C2CCCNN2C(=O)C(CC(C)C)NC(=O)C2CCCNN21 QCUFYOBGGZSFHY-UHFFFAOYSA-N 0.000 claims description 49
- 238000006243 chemical reaction Methods 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 26
- 238000012360 testing method Methods 0.000 claims description 24
- 150000003839 salts Chemical class 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000000853 adhesive Substances 0.000 claims description 5
- 230000001070 adhesive effect Effects 0.000 claims description 5
- 239000011541 reaction mixture Substances 0.000 claims description 5
- 239000004627 regenerated cellulose Substances 0.000 claims description 4
- 239000012528 membrane Substances 0.000 claims description 3
- 239000011363 dried mixture Substances 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 15
- 229920002307 Dextran Polymers 0.000 description 11
- 206010029719 Nonspecific reaction Diseases 0.000 description 11
- 230000004520 agglutination Effects 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 210000000601 blood cell Anatomy 0.000 description 8
- 239000011521 glass Substances 0.000 description 7
- 102000009027 Albumins Human genes 0.000 description 5
- 108010088751 Albumins Proteins 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- 238000009582 blood typing Methods 0.000 description 3
- 239000011111 cardboard Substances 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 229960002897 heparin Drugs 0.000 description 3
- 229920000669 heparin Polymers 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229920003002 synthetic resin Polymers 0.000 description 3
- 239000000057 synthetic resin Substances 0.000 description 3
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 239000002966 varnish Substances 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 235000021336 beef liver Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000009432 framing Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- SYUXAJSOZXEFPP-UHFFFAOYSA-N glutin Natural products COc1c(O)cc2OC(=CC(=O)c2c1O)c3ccccc3OC4OC(CO)C(O)C(O)C4O SYUXAJSOZXEFPP-UHFFFAOYSA-N 0.000 description 1
- -1 gold Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000003058 plasma substitute Substances 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- ZNCPFRVNHGOPAG-UHFFFAOYSA-L sodium oxalate Chemical compound [Na+].[Na+].[O-]C(=O)C([O-])=O ZNCPFRVNHGOPAG-UHFFFAOYSA-L 0.000 description 1
- 229940039790 sodium oxalate Drugs 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/150038—Source of blood for blood from umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150358—Strips for collecting blood, e.g. absorbent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK2770572X | 1951-07-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1005759B true DE1005759B (de) | 1957-04-04 |
Family
ID=8158676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DEN5823A Pending DE1005759B (de) | 1951-07-28 | 1952-07-21 | Zur Bestimmung von Blutgruppen verwendbare Karte |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US2770572A (cs) |
| BE (1) | BE513161A (cs) |
| DE (1) | DE1005759B (cs) |
| FR (1) | FR1079771A (cs) |
| NL (1) | NL89406C (cs) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0051748A1 (de) * | 1980-11-06 | 1982-05-19 | Biotest-Serum-Institut GmbH | Blutgruppenidentitätskarte, insbesondere für den Bed side-Test |
| EP0305337A1 (de) * | 1987-08-24 | 1989-03-01 | Stiftung Für Diagnostische Forschung | Verfahren zum Nachweis von Antigenen und/oder Antikörpern sowie Testausrüstung zur Durchführung des Verfahrens |
| US5338689A (en) * | 1987-08-24 | 1994-08-16 | Stiftung Fur Diagnostische Forschung | Method and card for detecting antigens and/or antibodies |
| US7871825B2 (en) | 2004-02-02 | 2011-01-18 | Medión Diagnostics AG | Test element and method for testing blood |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3035986A (en) * | 1959-01-02 | 1962-05-22 | Hyland Lab | Anti-m lectin from seeds of cruciferae iberis |
| NL129842C (cs) * | 1962-09-05 | |||
| US3272319A (en) * | 1962-10-05 | 1966-09-13 | Hynson Westcott & Dunning Inc | Immunological test kit |
| US3624223A (en) * | 1964-12-17 | 1971-11-30 | Technicon Instr | Blood type indicator |
| SE301893B (cs) * | 1965-12-08 | 1968-06-24 | Nordisk Insulinlab | |
| US3502437A (en) * | 1967-03-13 | 1970-03-24 | Haematronics Inc | Identification card |
| US3798423A (en) * | 1971-10-04 | 1974-03-19 | Medislide Ind Inc | Diagnostic data card construction |
| NL213501A (cs) * | 1972-03-10 | |||
| US3853468A (en) * | 1972-05-08 | 1974-12-10 | H Haymond | Method and apparatus for clinical testing of biological fluids |
| US3956477A (en) * | 1973-06-08 | 1976-05-11 | Akzona Incorporated | Method and erythrocyte preparation for reverse blood grouping |
| CA1039649A (en) * | 1973-08-30 | 1978-10-03 | General Electric Company | Method of forming multilayer immunologically complexed films |
| US3882224A (en) * | 1973-09-11 | 1975-05-06 | American Cyanamid Co | Reagents and tests for syphilis |
| US3949065A (en) * | 1973-09-11 | 1976-04-06 | American Cyanamid Company | Composition and method for the detection of syphilis |
| US4046871A (en) * | 1975-04-08 | 1977-09-06 | Ortho Diagnostics Inc. | Compositions and serological methods including bovine serum albumin polymers |
| GB1555142A (en) * | 1975-08-14 | 1979-11-07 | Sinai School Medicine | Blood cell typing and compatibility test procedure |
| US3990850A (en) * | 1976-01-06 | 1976-11-09 | Akzona Incorporated | Diagnostic test card |
| US4025310A (en) * | 1976-05-28 | 1977-05-24 | International Diagnostic Technology, Inc. | Method for reading a wet fluorescent surface |
| US4578282A (en) * | 1982-02-04 | 1986-03-25 | Harrison James S | Composition for diagnostic reagents |
| US4493821A (en) * | 1982-02-04 | 1985-01-15 | Harrison James S | Preservative and fixative preparations for biological systems |
| US5900379A (en) * | 1996-04-11 | 1999-05-04 | Mizuho Usa, Inc. | Analytical device |
| CA2309528C (en) | 1999-06-08 | 2007-10-09 | Ortho-Clinical Diagnostics, Inc. | Simultaneous determination of forward and reverse abo blood group |
| USD491276S1 (en) | 2002-12-09 | 2004-06-08 | Babette Langille | Plastic diagnostic card |
| US7419638B2 (en) | 2003-01-14 | 2008-09-02 | Micronics, Inc. | Microfluidic devices for fluid manipulation and analysis |
| EP1709451B1 (en) * | 2003-12-22 | 2008-02-27 | Micro Typing Systems, Inc. | Reducing time to result for blood bank diagnostic testing |
| WO2010040103A1 (en) | 2008-10-03 | 2010-04-08 | Micronics, Inc. | Microfluidic apparatus and methods for performing blood typing and crossmatching |
| EP2994750B1 (en) | 2013-05-07 | 2020-08-12 | PerkinElmer Health Sciences, Inc. | Microfluidic devices and methods for performing serum separation and blood cross-matching |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE22208E (en) * | 1942-10-20 | Composition capable of inhibiting | ||
| US1839573A (en) * | 1928-10-15 | 1932-01-05 | Herbert Killips | Apparatus for testing blood |
| US2194131A (en) * | 1936-07-30 | 1940-03-19 | Robert W Terry | System for conducting stained antigen tests |
| US2334636A (en) * | 1939-08-17 | 1943-11-16 | Indiana University Foundation | Syphilis test and antigen |
| US2357253A (en) * | 1940-08-01 | 1944-08-29 | Lederle Lab Inc | Preservation of dried blood grouping serum |
| US2561339A (en) * | 1944-01-10 | 1951-07-24 | Chediak Alejandro | Apparatus for laboratory investigations |
-
0
- NL NL89406D patent/NL89406C/xx active
- BE BE513161D patent/BE513161A/xx unknown
-
1952
- 1952-07-21 DE DEN5823A patent/DE1005759B/de active Pending
- 1952-07-24 US US300698A patent/US2770572A/en not_active Expired - Lifetime
- 1952-07-28 FR FR1079771D patent/FR1079771A/fr not_active Expired
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0051748A1 (de) * | 1980-11-06 | 1982-05-19 | Biotest-Serum-Institut GmbH | Blutgruppenidentitätskarte, insbesondere für den Bed side-Test |
| EP0305337A1 (de) * | 1987-08-24 | 1989-03-01 | Stiftung Für Diagnostische Forschung | Verfahren zum Nachweis von Antigenen und/oder Antikörpern sowie Testausrüstung zur Durchführung des Verfahrens |
| US5338689A (en) * | 1987-08-24 | 1994-08-16 | Stiftung Fur Diagnostische Forschung | Method and card for detecting antigens and/or antibodies |
| US5460940A (en) * | 1987-08-24 | 1995-10-24 | Stiftung Fur Diagnostische Forschung | Method for detecting antigens and/or antibodies |
| US7871825B2 (en) | 2004-02-02 | 2011-01-18 | Medión Diagnostics AG | Test element and method for testing blood |
Also Published As
| Publication number | Publication date |
|---|---|
| BE513161A (cs) | |
| FR1079771A (fr) | 1954-12-02 |
| NL89406C (cs) | |
| US2770572A (en) | 1956-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1005759B (de) | Zur Bestimmung von Blutgruppen verwendbare Karte | |
| DE2651139C3 (de) | Reagens zur Durchführung eines Direktagglutinationstests zum Schwangerschaftsnachweis und Verfahren zu seiner Herstellung | |
| DE2013558A1 (de) | Diagnostiziermittel zum Nachweis von Substanzen die mit einer Diazoverbindung unter Eintritt eines Farbwechsels kuppeln | |
| DE2602997C2 (de) | Lyophilisierte Kollagenzubereitung und Verfahren zu ihrer Herstellung | |
| DE3786799T2 (de) | Verfahren zur Korrektur der Kalibrierungskurve bei einem trockenen analytischen Prozess. | |
| DE1801278A1 (de) | Bilirubin-Diagnostikum | |
| DE3105555C2 (cs) | ||
| DE2021968A1 (de) | Verfahren zur Blutuntersuchung unter Verwendung radioaktiver Indikator-Substanzen und Ionenaustauscherharz-Membranen | |
| DE2309794C3 (de) | Testreagens zur Bestimmung von Ascorbinsäure | |
| DE2850950C3 (de) | Verwendung von nativem oder thermisch modifiziertem Cytochrom c als Stabilisator für ein immunochemisches Meßreagens, immunochemisches Meßreagens sowie Pufferlösung zur Probenverdünnung bei immunchemischen Meßverfahren | |
| DE1807255A1 (de) | Praeparat aus hinsichtlich ihrer Anzahl,Form und Volumen stabilisierter Suspensionen von organischen Partikelchen zur Konservierung mikroskopischer Partikelchen und zum Herstellen standardisierter Partikelchen-Suspensionen | |
| DE2835296A1 (de) | Vorrichtung zur herstellung von kontrolloesungen | |
| DE2023989C3 (de) | Verfahren zur Herstellung von aus Antigen-Trägerstoffgemischen bestehenden und gegebenenfalls Antikörper enthaltenden fertigen serodiagnostischen, auf einen Objektträger aufgebrachten lagerbeständigen Testsubstanzen | |
| DE69332764T2 (de) | Hydroxylamin enthaltendes kontrollreagenz | |
| EP0381091B1 (de) | Verfahren zur Bestimmung eines Enzyms aus einem Isoenzymgemisch sowie hierfür geeigneter Testträger und dessen Verwendung | |
| DE2314263A1 (de) | Synthetischer kontrollstandard zur analyse der cerebrospinalen fluessigkeit und seine herstellung | |
| EP0337467B1 (de) | Verfahren zur Bestimmung von Thyroxin und dazu geeignete Standardlösung | |
| CH311845A (de) | Zur Bestimmung von Blutgruppen bestimmtes Hilfsmittel. | |
| CH621876A5 (cs) | ||
| DE3786790T2 (de) | Qualitätskontrollsysteme. | |
| DE631658C (de) | Verfahren zur Herstellung von haltbaren Suspensionen tierischer Gewebezellen | |
| EP0034301A2 (de) | Verfahren zur Bestimmung von Immunkomplexen | |
| DE1617467C3 (de) | Verwendung einer wäßrigen Lösung eines Peroxides oder einer Peroxosäure oder eines Peroxosalzes zur Fixierung von Erythrozyten | |
| DE1943881C3 (de) | Verfahren zur quantitativen Bestimmung der Thrombinaktivität in Blutplasma und dessen Fraktionen | |
| DE1153920B (de) | Diagnostisches Mittel zur Bestimmung von Ketonverbindungen in Koerperfluessigkeiten |